date,title,source
Oct-17-18,"BioLineRx, High Potential Near Term Catalysts, Analysts Review and Target",ACCESSWIRE
Oct-19-18,BioLineRx Presents Top-line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress,PR Newswire
